Case Report: cytoreductive prostatectomy after platinum–etoposide chemotherapy for de novo metastatic prostatic small cell neuroendocrine carcinoma
Yanxin Wang, Qiwu Wang, Hang Yang · 2026
Read Case Report: cytoreductive prostatectomy after platinum–etoposide chemotherapy for de novo metastatic prostatic small cell neuroendocrine carcinoma by Yanxin Wang, Qiwu Wang, Hang Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623550.txt.
Description
Yanxin Wang, Qiwu Wang, and Hang Yang present a 2026 case report on surgery after drug therapy for a rare, fast-moving prostate cancer. This small cell type grows aggressively and often spreads before it is found. Removing the prostate after chemotherapy is not standard, so its benefits and risks need care in weighing.
The patient was a 50-year-old man with a year of worsening trouble passing urine. Tissue from an initial procedure confirmed the rare type, and scans showed spread to lymph nodes and likely to the lungs. Seven rounds of drug therapy shrank the prostate greatly. The report follows what surgery then offered and what it risked.
Catalog record
| CREATOR | Yanxin Wang, Qiwu Wang, Hang Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |